T
Tikun Olam Cannbit Pharmaceuticals Ltd
TASE:TKUN
Tikun Olam Cannbit Pharmaceuticals Ltd
TASE:TKUN
Price:
1 964
ILS
Market Closed
Market Cap:
₪16.7m
Balance Sheet
Balance Sheet Decomposition
Tikun Olam Cannbit Pharmaceuticals Ltd
Tikun Olam Cannbit Pharmaceuticals Ltd
Balance Sheet Decomposition is not available for
Tikun Olam Cannbit Pharmaceuticals Ltd
Tikun Olam Cannbit Pharmaceuticals Ltd
Balance Sheet
Tikun Olam Cannbit Pharmaceuticals Ltd
Tikun Olam Cannbit Pharmaceuticals Ltd
Currency: ILS
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
1
|
0
|
0
|
3
|
2
|
11
|
13
|
2
|
7
|
0
|
|
| Cash Equivalents |
1
|
0
|
0
|
3
|
2
|
11
|
13
|
2
|
7
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
1
|
8
|
9
|
11
|
16
|
7
|
5
|
|
| Accounts Receivables |
0
|
0
|
0
|
1
|
6
|
3
|
1
|
3
|
1
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
2
|
6
|
10
|
13
|
6
|
4
|
|
| Inventory |
0
|
0
|
0
|
0
|
4
|
18
|
15
|
21
|
10
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
1
|
3
|
4
|
5
|
0
|
0
|
|
| Total Current Assets |
1
|
0
|
0
|
3
|
14
|
41
|
43
|
43
|
24
|
6
|
|
| PP&E Net |
0
|
0
|
0
|
4
|
65
|
82
|
78
|
69
|
29
|
7
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
76
|
72
|
68
|
37
|
18
|
10
|
|
| Long-Term Investments |
5
|
5
|
0
|
0
|
0
|
0
|
1
|
7
|
5
|
0
|
|
| Total Assets |
5
N/A
|
5
-10%
|
0
-98%
|
7
+5 931%
|
155
+2 084%
|
195
+25%
|
190
-3%
|
157
-17%
|
77
-51%
|
24
-69%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
5
|
6
|
5
|
7
|
4
|
1
|
|
| Short-Term Debt |
0
|
0
|
1
|
0
|
8
|
8
|
10
|
10
|
13
|
11
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
1
|
1
|
|
| Other Current Liabilities |
0
|
1
|
0
|
0
|
8
|
11
|
6
|
8
|
11
|
7
|
|
| Total Current Liabilities |
0
|
1
|
1
|
2
|
22
|
26
|
23
|
27
|
28
|
20
|
|
| Long-Term Debt |
0
|
0
|
0
|
4
|
8
|
7
|
8
|
8
|
6
|
5
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
2
|
3
|
3
|
8
|
8
|
|
| Other Liabilities |
0
|
0
|
0
|
1
|
25
|
25
|
15
|
5
|
9
|
4
|
|
| Total Liabilities |
0
N/A
|
1
+129%
|
1
-9%
|
7
+1 049%
|
56
+692%
|
57
+3%
|
43
-24%
|
37
-14%
|
36
-4%
|
22
-40%
|
|
| Equity | |||||||||||
| Common Stock |
1
|
1
|
1
|
0
|
0
|
0
|
29
|
29
|
30
|
30
|
|
| Retained Earnings |
37
|
38
|
38
|
21
|
32
|
65
|
98
|
146
|
235
|
275
|
|
| Additional Paid In Capital |
63
|
63
|
59
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
22
|
22
|
22
|
21
|
132
|
203
|
215
|
236
|
246
|
247
|
|
| Total Equity |
5
N/A
|
4
-18%
|
0
N/A
|
0
N/A
|
100
+92 411%
|
138
+38%
|
147
+6%
|
120
-18%
|
41
-66%
|
2
-94%
|
|
| Total Liabilities & Equity |
5
N/A
|
5
-10%
|
0
-98%
|
7
+5 931%
|
155
+2 084%
|
195
+25%
|
190
-3%
|
157
-17%
|
77
-51%
|
24
-69%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
Switch to:
Switch to:
See Also
Discover More
